Cervical cancer worldwide. Cancer de col uterin - Wikipedia
The biologic behavior of squamous cervical carcinoma after neoadjuvant therapy NAT according to immunohistochemical expression of E-cadherin and CD44v6 Mihaela Madalina Gavrilescu, Raluca Balan, Viorel Scripcariu, Dan Ferariu, Ludmila Lozneanu, Diana Popovici, Cornelia Amalinei Abstract The efficiency of neoadjuvant therapy in cervical carcinoma has been well demonstrated, although the cellular mechanisms of different response to this treatment have not been thoroughly investigated.
The aim of our study was to assess the correlations between the alterations in E-cadherin and CD44v6 immunoexpression in cervical carcinoma, as a tool of evaluation the response to neoadjuvant therapy and its prognostic significance.
The intensity of CD44v6 immunoexpression was higher in more aggressive tumors and E-cadherin immunoexpression was approximately constant among the cases with neoadjuvant therapy. Our results cervical cancer worldwide that the evaluation of CD44v6 immunoexpression in cervical carcinomas is useful for the assessment of tumor response to neoadjuvant therapy and of tumor aggressiveness.
The high level of E-cadherin immunoexpression in tumors with neoadjuvant therapy reflects its involvement in the prevention of HPV oncoproteins action, with benefits on the outcome.
A larger group of patients and a panel of antibodies, including CD4 cervical cancer worldwide COX2, could provide a better characterization of the tumor response to neoadjuvant therapy, with a positive prognosis impact. Int J Cancer ; Rom J Morphol Embryol ; CD44 isoform 6 CD44v6 is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma.
Gynecol Oncol ; 80 1 CD 44 exon v6 as a predictor of lymphatic metastases in cervical carcinoma--an immunocytochemical study of 94 cases.
Cervical Cancer: What To Know
Arch Gynecol Obstet ; 3 cervical cancer worldwide Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer. Int J Cancer ; 69 3 CD44 is an independent prognostic factor in early-stage cervical cancer.
Involvement of Human Papillomavirus genome in oncogenesis of cervical cancer
Int J Cancer ; 74 2 E-cadherin and alpha-catenin expression during tumor progression of cervical carcinoma. Gynecol Oncol ; Braz Dent J ; 20 1 Anticancer Res ; Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma.
- Papillomavirus in mouth symptoms
- Cancer de col uterin - Wikipedia
- El papiloma humano produce cancer de utero
- Papilloma on vocal cord
- The virus infects basal epithelial cells of stratified squamous epithelium.
- University of Texas M.
- Global, HPV este cea mai frecvent transmisă infecţie sexuală, deşi există variaţii regionale semnificative n prevalenţa HPV n regiunile cu aglomeraţie populaţională şi descendenţă comună, ceea ce se poate datora diferenţelor n ceea ce priveşte normele culturale şi sexuale [7].
J Pathol ; 2 Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol ; Hirohashi S, Kanai Cervical cancer worldwide.
- Vaccinul Cervarix al GSK primeste aut
- Pin on punct&de la capat..
- Implicarea genomului papiloma virusului uman (hpv) în oncogeneza cancerului cervical
- Ovarian cancer genetic testing
- Hpv virus eye problems
Cell adhesion system and human cancer morphogenesis. Cancer Sci ; HPV16 E7 oncogene expression in normal cervical cancer worldwide epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition. Virology ; 1 Tumor biomarkers in cervical cancer: focus on Ki proliferation factor and E-cadherin expression. Significance of E-cadherin, beta-catenin, and vimentin expression as postoperative prognosis indicators in cervical squamous cell carcinoma.
Hum Pathol ;
